Results 101 to 110 of about 4,001,428 (243)

Lorlatinib‐Containing Therapy for MYCN‐Amplified, ALK‐Mutated Neuroblastoma With Bulky Leptomeningeal Relapse: A Case Report

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Central nervous system (CNS) relapse of neuroblastoma carries a poor prognosis, and craniospinal irradiation (CSI) poses substantial long‐term toxicity in young children. We report a toddler with MYCN‐amplified neuroblastoma harboring somatic ALK R1275Q who developed extensive leptomeningeal relapse with paraplegia.
Jinwoo Kim   +11 more
wiley   +1 more source

SH2 Domains: Folding, Binding and Therapeutical Approaches. [PDF]

open access: yesInt J Mol Sci, 2022
Diop A   +9 more
europepmc   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye   +33 more
wiley   +1 more source

The Therapeutical Hemapheresis National Registry: Computerization Proposals

open access: yes, 1998
The therapeutical hemapheresis National Registry, founded under the patronage of S.I.d.E., is now in its second year. It was set up to meet the need to gather experience from the various Italian groups dealing with hemapheresis and based on the former ...
E. Vitaliano, G.E. Russo, N. Leopardi
core   +1 more source

Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola   +4 more
wiley   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

Forecasting the Dialysis Burden in Japan: Validation‐Based Projections of Prevalence and Incidence Through 2050

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin   +2 more
wiley   +1 more source

Fecal Serine-Protease Activity: A Pathophysiological Marker and Possible Therapeutical Target in Diarrhea-Predominant Irritable Bowel Syndrome

open access: yes, 2006
Fecal Serine-Protease Activity: A Pathophysiological Marker and Possible Therapeutical Target in Diarrhea-Predominant Irritable Bowel Syndrome.
Lévêque, Mathilde   +8 more
core   +2 more sources

Advances in Crystallization and Precipitation Technologies for Biotherapeutics

open access: yes
: Modeling approaches can help develop and optimize precipitation and crystallization for a wide range of therapeutical products, such as monoclonal antibodies and Adeno-associated ...
Springs, Stacy L.   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy